£1.53m
−31%vs Mar 2024Active12474195Private limited companyLondon
CELIX PHARMA LTD
B72/10001
Summary
CELIX PHARMA LTD is an active private limited company (company number 12474195) incorporated on 20 February 2020, registered in London. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest small accounts cover the period ending 31 March 2025, showing net assets of £1.53m and cash of £148k, with 3 employees on average. Net assets fell 31% on the prior period (£2.21m).
Peer position · net assets
By net assets it sits in the top quarter of 76 comparable companies in London (median £100, upper quartile £88k).
02
Key dates
- Incorporated
- 20 February 20206 yrs ago
- Next accounts due
- 31 December 2026in 70 days
- Confirmation statement due
- 6 March 2027in 135 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
04
Financials
£148k
−87%vs Mar 2024Not reported
3
+200%vs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £1.53m | £148k | £987k | £2.34m | — | — | 3 |
| 31 March 2024 | £2.21m | £1.17m | £693k | £545k | — | — | 1 |
Current ratio1.65Comfortable
Cash per employee£49kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
05
Firmoscan score
72 / 100 · grade B
| 50 | Starting scoreEvery scored company starts here |
| +10 | Positive net assetsNet assets £1,527,377 at 2025-03-31 |
| −8 | Net assets falling-30.9% vs prior period |
| +8 | Comfortable liquidityCurrent ratio 1.65 |
| +4 | Cash reservesCash £148,435 |
| +8 | EstablishedIncorporated 2020-02-20 (7 years) |
| 72 | Score, grade B |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
06
Ownership and control
- Mr. Subir Kohli
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
- Mr. Shantreddy Channareddy Soogareddy
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mrs Amrita Kohli
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Confirmation statement duein 135 days
- Next accounts duein 70 days
- Accounts period endNet assets £1.53m · small accounts
- Accounts period endNet assets £2.21m · small accounts
- Incorporated
08
Similar companies in London
- COHEN GLOBAL LIMITEDLondon · inc. Feb 2020
- INTRACELL THERAPEUTICS UK LIMITEDLondon · inc. Feb 2020
- PNA LOCUM LIMITEDLondon · inc. Jan 2020
- ORBYT GROUP LTDLondon · inc. May 2020
- MED X PHARMA TECH UK LIMITEDLondon · inc. Jul 2020
- FENSTER CONSULTANTS LTDLondon · inc. Jul 2020
All companies incorporated on 20 February 2020 · in Feb 2020.
09
Reminders for CELIX PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.